Original ArticlesMagnetic Resonance Angiography of Abdominal Vessels at 3 TMeaney, James F.M. FRCR*†; Fagan, Andrew J. PhD*†; Beddy, Peter FRCR‡Author Information From the *Centre for Advanced Magnetic Resonance Imaging, St. James's Hospital; †Trinity College Dublin, Ireland; and ‡Beth Israel Deaconess Medical Center, Boston, MA. Reprints: James F.M. Meaney, MD, Magnetic Resonance Imaging Department, St. James's Hospital, Dublin 8, Ireland (e-mail: firstname.lastname@example.org). AJF and PB have no conflicts of interest to declare. JRM has authored several patents on contrast-enhanced MRA which are licensed to several MR and contrast agent manufacturers. Topics in Magnetic Resonance Imaging: June 2010 - Volume 21 - Issue 3 - p 189-197 doi: 10.1097/RMR.0b013e318228ca49 Buy Metrics Abstract Magnetic resonance angiography (MRA) has evolved significantly since first described in the early 1990s. Unrivaled image quality and freedom from artifacts has made it a reliable and widely utilized technique. Imaging at 3 T offers the potential for higher resolutions images with better temporal resolution compared to 1.5 T. This article will review the technique and contrast agents required to perform MRA at 3 T and the relevant clinical applications. We also discuss non-contrast enhanced MRA in the era of nephrogenic systemic fibrosis and future prospect for MRA at 3 T. © 2010 Lippincott Williams & Wilkins, Inc.